Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2)

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Archives of Virology

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00705-002-0870-yPMID 12417948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Laboratory Diagnosis of Viral Infections

  2010cited by this paper
• Cutting Edge: Recombinant Adenoviruses Induce CD8 T Cell Responses to an Inserted Protein Whose Expression Is Limited to Nonimmune Cells

  2001cited by this paper
• Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors

  2001cited by this paper
• The role of the antibody response in influenza virus infection.

  2001cited by this paper
• Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.

  2001cited by this paper
• Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

  2001cited by this paper
• Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: Identification of functional themes

  2001cited by this paper
• The epidemiology and evolution of influenza viruses in pigs.

  2000cited by this paper
• Biophysical targeting of adenovirus vectors for gene therapy.

  2000cited by this paper
• Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes.

  2000cited by this paper
• Evolution of Swine H3N2 Influenza Viruses in the United States

  2000cited by this paper
• Biophysical targeting of adenovirus vectors for gene therapy.

  2000cited by this paper
• Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States

  2000cited by this paper
• Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs.

  2000cited by this paper
• Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies.

  2000cited by this paper
• Adenovirus vectors for gene delivery.

  1999influential reference
• Genetic Reassortment of Avian, Swine, and Human Influenza A Viruses in American Pigs

  1999cited by this paper
• DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice

  1999cited by this paper
• Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.

  1999cited by this paper
• Viral vector targeting.

  1999influential reference
• CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice.

  1999cited by this paper
• Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA

  1998cited by this paper
• Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus

  1998cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998influential reference
• Protective Role of Gamma Interferon during the Recall Response to Influenza Virus

  1998cited by this paper
• Clearance of an Influenza A Virus by CD4+ T Cells Is Inefficient in the Absence of B Cells

  1998cited by this paper
• Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin

  1997cited by this paper
• Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.

  1997cited by this paper
• Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy.

  1997cited by this paper
• Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

  1997cited by this paper
• Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection.

  1997cited by this paper
• Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.

  1997cited by this paper
• Long‐term humoral and cellular immunity induced by a single immunization with replication‐defective adenovirus recombinant vector

  1995cited by this paper
• The use of DNA viruses as vectors for gene therapy.

  1994influential reference
• Neutralization of Animal Viruses

  1993cited by this paper
• The molecular biology of influenza viruses and paramyxoviruses

  1993cited by this paper
• Adenovirus-based expression vectors and recombinant vaccines.

  1992cited by this paper
• Influenza: pathogenesis and host defense.

  1992cited by this paper
• The immune response to influenza vaccines.

  1990cited by this paper
• Influenza: pathogenesis and host defense.

  1990cited by this paper
• Genes and Proteins of the Influenza Viruses

  1989cited by this paper
• The immune response of humans to live and inactivated influenza vaccines.

  1989cited by this paper
• Structure, Function, and Antigenicity of the Hemagglutinin of Influenza Virus

  1989cited by this paper
• Specificity and Function of T Lymphocytes Induced by Influenza A Viruses

  1989cited by this paper
• The immune response to influenza infection.

  1986cited by this paper
• Biological and immunological properties of haemagglutinin and neuraminidase expressed from cloned cDNAs in prokaryotic and eukaryotic cells.

  1985cited by this paper

• Generation of a thermostable, oral Zika vaccine that protects against virus challenge in non-human primates.

  2023cites this paper
• The Next Generation of Influenza Vaccines: Towards a Universal Solution

  2021influential citation
• Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

  2020cites this paper
• Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation

  2018cites this paper
• Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus

  2017cites this paper
• Transgenic Plant Expressed Hemaggulutinin against Low Pathogenic Avian Influenza Virus

  2017cites this paper
• Yeast Surface-Displayed H5N1 Avian Influenza Vaccines

  2016cites this paper
• Viral vector-based influenza vaccines

  2016cites this paper
• Vaccines and vaccination for swine influenza: differing situations in Europe and the USA

  2016cites this paper
• Efficacy and immunogenicity of recombinant swinepox virus expressing the A epitope of the TGEV S protein

  2015cites this paper
• Adenoviral vectors as novel vaccines for influenza

  2015cites this paper
• The Socio-Economic Impact of Controlled and Notifiable Wildlife Diseases in the Southern African Development Community (SADC) States of Africa

  2014cites this paper
• All-in-One Bacmids: an Efficient Reverse Genetics Strategy for Influenza A Virus Vaccines

  2014cites this paper
• An Overview of Live Attenuated Recombinant Pseudorabies Viruses for Use as Novel Vaccines

  2014cites this paper
• Virus-Vectored Influenza Virus Vaccines

  2014cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs.

  2013cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• LIVE-ATTENUATED VACCINES AGAINST INFLUENZA VIRUSES AND ROLE OF NS1 IN HOST RESPONSE

  2013cites this paper
• Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09.

  2013cites this paper
• Swine influenza virus vaccines: to change or not to change-that's the question.

  2013cites this paper
• Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.

  2012influential citation
• An Adenovirus-Based Vaccine with a Double-Stranded RNA Adjuvant Protects Mice and Ferrets against H5N1 Avian Influenza in Oral Delivery Models

  2012cites this paper
• Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.

  2012influential citation
• Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice.

  2010cites this paper
• Swine influenza vaccines: current status and future perspectives

  2010cites this paper
• Production of adenovirus vectors and their use as a delivery system for influenza vaccines

  2010cites this paper
• The potential of a novel Adenovirus vector for vaccination.

  2010cites this paper
• Vaccin recombinant contre le paramyxovirus aviaire, sa méthode de fabrication et dutilisation

  2010cites this paper
• Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.

  2009cites this paper
• Avian influenza vaccines and therapies for poultry.

  2009cites this paper
• First Characterization of Avian Memory T Lymphocyte Responses to Avian Influenza Virus Proteins

  2009cites this paper
• Targeting the porcine immune system—Particulate vaccines in the 21st century

  2008cites this paper
• Oral adenoviral-based vaccines: historical perspective and future opportunity

  2008cites this paper
• Influenza vaccines and vaccination strategies in birds.

  2008cites this paper
• Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus.

  2008cites this paper
• Influence of porcine reproductive and respiratory syndrome virus GP5 glycoprotein N-linked glycans on immune responses in mice

  2007cites this paper
• Influenza. Vacunas clásicas y novedosas a las puertas de otra pandemia

  2006cites this paper
• [Recombinant viruses of poultry as vector vaccines against fowl plague].

  2006cites this paper
• Replication-defective viruses as vaccines and vaccine vectors.

  2006cites this paper
• A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge.

  2006influential citation
• Use of adenoviral vectors as veterinary vaccines

  2005cites this paper
• Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus.

  2005cites this paper
• Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus Immunization

  2005cites this paper
• Application of new vaccine technologies for the control of transboundary diseases.

  2004cites this paper
• Mucosal immunity

  2004cites this paper
• Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.

  2004cites this paper